Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Portal Instruments has developed a reusable, computer-controlled needle-free injector designed to deliver high-viscosity biologic drugs subcutaneously. The technology aims to improve patient experience and adherence by eliminating needles and enabling at-home administration. In partnership with Takeda, Portal's device has been evaluated for use with Entyvio in inflammatory bowel disease patients. The company continues to expand its electro-mechanical drug delivery platforms and offers engineering services to pharma/biotech clients for custom projects. No independent clinical efficacy results are published by Portal itself since it provides enabling technology rather than therapeutics directly.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Portal Instruments.